Condition: Bone Fractures · Bone Defects · Bone Loss · Sponsor: Artur Salgado SA
The objective of this study is to evaluate the safety and performance of AdvanCore implantable bone graft through a 12-month follow-up period in a prospective, parallel-group design, non-controlled, open label, multi-center and real-world setting study. This study is intended to satisfy post-market clinical follow-up requirements of CE Mark in Europe.
This description comes directly from the study's public registry record.
Francisca C Costa · +351253794649 · f.costa@artursalgado.pt
Always discuss trial participation with your own doctor first.
| Unidade Local de Saúde do Alto Ave | Guimarães, Braga District, Portugal | Recruiting |
| Unidade Local de Saúde de São João | Porto, Porto District, Portugal | Not Yet Recruiting |
| Unidade Local de Saúde do Médio Tejo | Tomar, Santarém District, Portugal | Not Yet Recruiting |
| Unidade Local de Saúde de Trás-os-Montes e Alto Douro | Lordelo, Vila Real District, Portugal | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06736457